Literature DB >> 32776503

Online/at-line measurement, analysis and control of product titer and critical product quality attributes (CQAs) during process development.

Letha Chemmalil1, Tanushree Prabhakar2, June Kuang1, Jay West3, Zhijun Tan4, Vivekh Ehamparanathan4, Yuanli Song4, Jianlin Xu4, Julia Ding1, Zhengjian Li4.   

Abstract

Process analytical technology (PAT) has been defined by the Food and Drug Administration as a system for designing, analyzing, and controlling manufacturing through timely measurements to ensure final product quality. Based on quality-by-design (QbD) principles, real-time or near-real-time data monitoring is essential for timely control of critical quality attributes (CQAs) to keep the process in a state of control. To facilitate next-generation continuous bioprocessing, deployment of PAT tools for real-time monitoring is integral for process understanding and control. Real-time monitoring and control of CQAs are essential to keep the process within the design space and align with the guiding principles of QbD. The contents of this manuscript are pertinent to the online/at-line monitoring of upstream titer and downstream product quality with timely process control. We demonstrated that an ultra-performance liquid chromatography (UPLC) system interfaced with a UPLC-process sample manager (UPLC-PSM) can be utilized to measure titer and CQAs directly from bioreactors and downstream unit operations, respectively. We established online titer measurements from fed-batch and perfusion-based alternating tangential flow bioreactors as well as product quality assessments of downstream operations for real-time peak collection. This integrated, fully automated system for online data monitoring with feedback control is designed to achieve desired product quality.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  HPLC; UV/Vis spectroscopy; continuous processing; monoclonal antibody; process analytical technology; quality by design

Mesh:

Substances:

Year:  2020        PMID: 32776503     DOI: 10.1002/bit.27531

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  7 in total

1.  Sensing Methodology for the Rapid Monitoring of Biomolecules at Low Concentrations over Long Time Spans.

Authors:  Rafiq M Lubken; Max H Bergkamp; Arthur M de Jong; Menno W J Prins
Journal:  ACS Sens       Date:  2021-12-02       Impact factor: 7.711

2.  Exploring the limits of conventional small-scale CHO fed-batch for accelerated on demand monoclonal antibody production.

Authors:  Amélie Mahé; Alexandra Martiné; Séverine Fagète; Pierre-Alain Girod
Journal:  Bioprocess Biosyst Eng       Date:  2021-11-09       Impact factor: 3.210

3.  Real-Time Monitoring of Biomolecules: Dynamic Response Limits of Affinity-Based Sensors.

Authors:  Rafiq M Lubken; Arthur M de Jong; Menno W J Prins
Journal:  ACS Sens       Date:  2022-01-03       Impact factor: 7.711

Review 4.  Recent Advances and Future Directions in Downstream Processing of Therapeutic Antibodies.

Authors:  Allan Matte
Journal:  Int J Mol Sci       Date:  2022-08-04       Impact factor: 6.208

5.  Continuous biomarker monitoring with single molecule resolution by measuring free particle motion.

Authors:  Alissa D Buskermolen; Yu-Ting Lin; Laura van Smeden; Rik B van Haaften; Junhong Yan; Khulan Sergelen; Arthur M de Jong; Menno W J Prins
Journal:  Nat Commun       Date:  2022-10-13       Impact factor: 17.694

6.  At-Line Reversed Phase Liquid Chromatography for In-Process Monitoring of Inclusion Body Solubilization.

Authors:  Julian Ebner; Diana Humer; Robert Klausser; Viktor Rubus; Reinhard Pell; Oliver Spadiut; Julian Kopp
Journal:  Bioengineering (Basel)       Date:  2021-06-07

7.  Technology transfer of a monitoring system to predict product concentration and purity of biopharmaceuticals in real-time during chromatographic separation.

Authors:  Anna Christler; Theresa Scharl; Dominik G Sauer; Johannes Köppl; Anne Tscheließnig; Cabir Toy; Michael Melcher; Alois Jungbauer; Astrid Dürauer
Journal:  Biotechnol Bioeng       Date:  2021-07-03       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.